Dernek Hakkında Tıbbi Onkoloji Derneği Haberler

The Lancet Oncology - Aralık 2010

Vol 11 No: 12 December 2010 p 1107-1200

ARTICLES
 
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
FH01 collaborative teams
[Full Text]
 
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Jack Cuzick, Ivana Sestak, Michael Baum, Aman Buzdar, Anthony Howell, Mitch Dowsett, John F Forbes, on behalf of the ATAC/LATTE investigators
[Full Text]
 
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study
Birgit Gruenberger, Johannes Schueller, Ute Heubrandtner, Fritz Wrba, Dietmar Tamandl, Klaus Kaczirek, Rudolf Roka, Sandra Freimann-Pircher, Thomas Gruenberger
[Full Text]
 
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
Wyndham H Wilson, Owen A O'Connor, Myron S Czuczman, Ann S LaCasce, John F Gerecitano, John P Leonard, Anil Tulpule, Kieron Dunleavy, Hao Xiong, Yi-Lin Chiu, Yue Cui, Todd Busman, Steven W Elmore, Saul H Rosenberg, Andrew P Krivoshik, Sari H Enschede, Rod A Humerickhouse
[Full Text]
 
 
REVIEW
 
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
Adrian M Jubb, Adrian L Harris
[Full Text

 

 
Lung cancer after treatment for breast cancer
Paul Lorigan, Raffaele Califano, Corinne Faivre-Finn, Anthony Howell, Nick Thatcher
[Full Text